All In MedTech

Device Trial Radar · NCT05639309

Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus

Pilot Study to Evaluate the Usefulness of Liver Regional Oxygen Saturation (RSO2) in Preterm Patent Ductus Arteriosus

Last checked: Nov 20, 2026Latest source record: May 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jan 13, 2023

Primary completion

Mar 31, 2025

Study completion Mar 31, 2025

Sponsor

Lead sponsor
Seoul St. Mary's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Research Foundation of Korea
First posted
Dec 6, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, up to 4 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the usefulness of liver perfusion and oxygenation status using regional oxygen saturation (RSO2) values obtained via near-infrared spectroscopy in assessing the hemodynamical significance of patent ductus arteriosus in preterm infants.

Conditions

  • Patent Ductus Arteriosus
  • Circulation
  • Newborn Morbidity
  • Premature Birth

Interventions

  • near-infrared spectroscopy based cerebral/somatic oximeter system (INVOS™ system manufactured by Medtronics)Device

    regional oxygen saturation measurement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Day 2 liver regional oxygen saturationTime frame: 48 to 72 hours of birth

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul St. Mary's Hospital

    Seoul, Seocho-Gu, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.